Impact of Apo E gene polymorphism on HCV therapy related outcome in a cohort of HCV Egyptian patients

The functional apolipoprotein E (Apo E) gene polymorphism could be used as a determinant of outcome of HCV infection. This study aimed to demonstrate the impact of Apo E genotype on the response to HCV combined therapy. Material and methods: The study has been implemented on 125 individuals with per...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomaa, Howayda E., Mahmoud, Mohamed, Saad, Nevine E., Saad-Hussein, Amal, Ismail, Somaia, Thabet, Eman H., Farouk, Hebatallah, Kandil, Dina, Heiba, Ahmed, Hafez, Wael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Scientific Research and Technology, Egypt 2018
Materias:
Medical Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296613/
https://www.ncbi.nlm.nih.gov/pubmed/30647703
http://dx.doi.org/10.1016/j.jgeb.2017.10.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296613/
https://www.ncbi.nlm.nih.gov/pubmed/30647703
http://dx.doi.org/10.1016/j.jgeb.2017.10.008

Ejemplares similares